ADC antibody-drug conjugates
10 companies · 12 assets
Taiwan biotech track map | Drugnews
bispecific antibodies and immunotherapy
4 companies · 4 assets
CAR-T and cell therapy
18 companies · 29 assets
nucleic-acid and gene therapy
4 companies · 5 assets
GLP-1, obesity and metabolism
9 companies · 10 assets
HDAC inhibitors
1 companies · 1 assets
improved new drugs and novel formulations
6 companies · 6 assets
radiopharmaceuticals and radioligand therapy
2 companies · 2 assets
Cancer immunotherapy
11 companies · 16 assets
Central nervous system
36 companies · 56 assets
Dermatology
11 companies · 13 assets
Gene therapy
2 companies · 2 assets
Ophthalmology
16 companies · 21 assets
Rare diseases
2 companies · 2 assets
COVID-19 and vaccines
16 companies · 22 assets